Literature DB >> 26424705

Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery.

Anne Sophie Schneck1,2, Rodolphe Anty3,2, Albert Tran3,2, Audrey Hastier3, Imed Ben Amor1, Jean Gugenheim1,2, Antonio Iannelli1,2, Thierry Piche4,5.   

Abstract

BACKGROUND: Only a few recent reports have suggested a correlation between obesity and irritable bowel syndrome (IBS). We aimed to determine the prevalence and severity of IBS in a prospective cohort of obese patients undergoing bariatric surgery in Nice Hospital (France).
METHODS: One hundred obese patients were included prospectively before bariatric surgery. A diagnosis of IBS and each subtype was performed according to Rome-III criteria using a Bristol scale for stool consistency. Patients provided information on IBS-related comorbidities, including chronic fatigue, migraine, lower back pain, gastroesophageal reflux disease (GERD), genitourinary problems, and dyspepsia. Patients completed questionnaires to assess the severity of IBS, GERD, psychological factors (anxiety, depression), fatigue, and quality of life.
RESULTS: Thirty patients fulfilled the Rome-III criteria for IBS. There was no difference in age, gender, or BMI between obese patients with or without IBS. Obese patients with IBS reported a significantly higher prevalence of GERD, migraines, lower back pain, genitourinary problems, chronic fatigue, and dyspepsia. Obese patients with IBS had significant higher scores of fatigue, anxiety, depression, and poorer quality of life. Obese patients that had both IBS and GERD had significantly higher IBS severity scores than those without GERD. In a logistic regression model including BMI, anxiety, depression, gender, and GERD score, only anxiety was significantly and independently associated with IBS.
CONCLUSIONS: Thirty percent of obese patients had IBS: its severity was not correlated with BMI. However, anxiety was independently associated with IBS, suggesting that psychological factors are key features of IBS, whatever the presence of obesity.

Entities:  

Keywords:  IBS; Obesity

Mesh:

Year:  2016        PMID: 26424705     DOI: 10.1007/s11695-015-1907-0

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  27 in total

1.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.

Authors:  C Y Francis; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

2.  Impact of fatigue on the quality of life of patients with primary biliary cirrhosis.

Authors:  P M Huet; J Deslauriers; A Tran; C Faucher; J Charbonneau
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

3.  Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery.

Authors:  Marinos Fysekidis; Michel Bouchoucha; Hélène Bihan; Gérard Reach; Robert Benamouzig; Jean-Marc Catheline
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

4.  Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study.

Authors:  Silvia Delgado-Aros; G Richard Locke; Michael Camilleri; Nicholas J Talley; Sara Fett; Alan R Zinsmeister; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

5.  Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass.

Authors:  Ronald H Clements; Quintin H Gonzalez; Allen Foster; William O Richards; James McDowell; Anthony Bondora; Henry L Laws
Journal:  Obes Surg       Date:  2003-08       Impact factor: 4.129

6.  The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome.

Authors:  Riadh Sadik; Einar Björnsson; Magnus Simrén
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-01       Impact factor: 2.566

7.  Irritable bowel syndrome in France: a common, debilitating and costly disorder.

Authors:  Michel Dapoigny; Jérôme Bellanger; Bruno Bonaz; Stanislas Bruley des Varannes; Lionel Bueno; Benoît Coffin; Philippe Ducrotté; Bernard Flourié; Marc Lémann; Anne Lepicard; Olivier Reigneau
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 2.566

8.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

Authors:  J D Fisk; P G Ritvo; L Ross; D A Haase; T J Marrie; W F Schlech
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

Review 9.  Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.

Authors:  Alexander C Ford; Eamonn M M Quigley; Brian E Lacy; Anthony J Lembo; Yuri A Saito; Lawrence R Schiller; Edy E Soffer; Brennan M R Spiegel; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2014-07-29       Impact factor: 10.864

Review 10.  Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

Authors:  Yan-Yan Ma; Lin Li; Chao-Hui Yu; Zhe Shen; Li-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

View more
  10 in total

Review 1.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

2.  Discovery of Drug Candidates for Specific Human Disease Based on Natural Products of Gut Microbes.

Authors:  Cheng-Yu Wang; Qing-Feng Wen; Qiao-Qiao Wang; Xia Kuang; Chuan Dong; Zi-Xin Deng; Feng-Biao Guo
Journal:  Front Microbiol       Date:  2022-06-15       Impact factor: 6.064

Review 3.  The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis.

Authors:  Changhyun Lee; Eunyoung Doo; Ji Min Choi; Seung-Ho Jang; Han-Seung Ryu; Ju Yup Lee; Jung Hwan Oh; Jung Ho Park; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

4.  A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study.

Authors:  Martin Aasbrenn; Stian Lydersen; Per G Farup
Journal:  J Obes       Date:  2018-03-01

5.  Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study.

Authors:  Martin Aasbrenn; Ingvild Høgestøl; Inger Eribe; Jon Kristinsson; Stian Lydersen; Tom Mala; Per G Farup
Journal:  BMC Obes       Date:  2017-06-29

6.  Clinical utility of the Montgomery-Åsberg Depression Rating Scale for the detection of depression among bariatric surgery candidates.

Authors:  Leorides Severo Duarte-Guerra; Clarice Gorenstein; Paula Francinelle Paiva-Medeiros; Marco Aurélio Santo; Francisco Lotufo Neto; Yuan-Pang Wang
Journal:  BMC Psychiatry       Date:  2016-04-30       Impact factor: 3.630

Review 7.  Diarrhea after bariatric procedures: Diagnosis and therapy.

Authors:  Yves M Borbély; Alice Osterwalder; Dino Kröll; Philipp C Nett; Roman A Inglin
Journal:  World J Gastroenterol       Date:  2017-07-14       Impact factor: 5.742

8.  Is body mass index associated with symptom severity and health-related quality of life in irritable bowel syndrome? A cross-sectional study.

Authors:  Yuanjun Dong; Sabrina Berens; Wolfgang Eich; Rainer Schaefert; Jonas Tesarz
Journal:  BMJ Open       Date:  2018-10-17       Impact factor: 2.692

9.  Associations of chronic diarrhoea with non-alcoholic fatty liver disease and obesity-related disorders among US adults.

Authors:  Andrea Shin; Huiping Xu; Thomas F Imperiale
Journal:  BMJ Open Gastroenterol       Date:  2019-08-12

Review 10.  Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?

Authors:  Huw Purssell; Peter J Whorwell; Varinder S Athwal; Dipesh H Vasant
Journal:  World J Hepatol       Date:  2021-12-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.